Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016)

Insight Molecular Diagnostics' (IMDX) quarterly Current Taxes came in at $151000.0 in Q4 2016, up 277.5% year-on-year from $40000.0 in Q1 2016, and little changed quarter-over-quarter from $151000.0 in Q3 2016.

Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016) Analysis & Trends

Insight Molecular Diagnostics has disclosed Current Taxes across 2 years of filings, most recently posting $151000.0 for Q4 2016.

  • Current Taxes for Q4 2016 came in at $151000.0, up 277.5% year-over-year; the trailing twelve-month figure through Dec 2016 was $151000.0 (up 277.5% YoY), and the FY2016 annual result was $151000.0, up 277.5% from the prior year.
  • Current Taxes came in at $151000.0 for Q4 2016 at Insight Molecular Diagnostics, roughly flat from $151000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $151000.0 in Q2 2016 to a low of $40000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn 47.00 Mn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn -
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn -
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn -
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn -
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn 172.00 Mn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn -
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn -
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn 161.48 Mn
10 Insight Molecular Diagnostics 4.34 Mn -24.59 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2016 151,000.00
Sep 30, 2016 151,000.00
Jun 30, 2016 151,000.00
Dec 31, 2015 40,000.00